Leukaemia (chronic lymphocytic, relapsed) - rituximab: consultee and commentator comments on the ACD
Leukaemia (chronic lymphocytic, relapsed) - rituximab: consultee and commentator comments on the ACD - Royal College of Pathologists
Leukaemia (chronic lymphocytic, relapsed) - rituximab: consultee and commentator comments on the ACD - RCN
Leukaemia (chronic lymphocytic, relapsed) - rituximab: consultee and commentator comments on the ACD - Cancer Research UK
Leukaemia (chronic lymphocytic, relapsed) - rituximab: consultee and commentator comments on the ACD - Roche
This page was last updated: 30 March 2010